FDA approves Rydapt for adults with acute myeloid leukemia
Friday, April 28, 2017 - 14:31
in Health & Medicine
Rydapt has been approved by the FDA, in combination with chemotherapy, to treat adults with acute myeloid leukemia who have the specific genetic mutation FLT3.